-
1
-
-
0025766667
-
The Management of the Levodopa Psychoses
-
Friedman J. The Management of the Levodopa Psychoses. Clin Neuropharmacol 1991; 14: 283-294.
-
(1991)
Clin Neuropharmacol
, vol.14
, pp. 283-294
-
-
Friedman, J.1
-
3
-
-
0027761975
-
Neuropsychological and psychiatric side effects in the treatment of Parkinsons's Disease
-
Saint-Cyr J, Taylor A, Lang A. Neuropsychological and psychiatric side effects in the treatment of Parkinsons's Disease. Neurology 1993; 43 (Suppl): S47-S53.
-
(1993)
Neurology
, vol.43
, Issue.SUPPL.
-
-
Saint-Cyr, J.1
Taylor, A.2
Lang, A.3
-
5
-
-
0027398865
-
Ondansetron for hallucinosis in advanced Parkinson's disease
-
Zoldan J, Friedberg G, Goldberg-Stern H, Melamed E. Ondansetron for hallucinosis in advanced Parkinson's disease. [letter] Lancet 1993; 341: 562-563.
-
(1993)
Lancet
, vol.341
, pp. 562-563
-
-
Zoldan, J.1
Friedberg, G.2
Goldberg-Stern, H.3
Melamed, E.4
-
6
-
-
0029161630
-
Psychosis in advanced Parkinson's disease: Treatment with ondansetron, a 5-HT receptor antagonist
-
Zoldan J, Friedberg G, Livneh M, Melamed E. Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT receptor antagonist. Neurology 1995; 45: 1305-1308.
-
(1995)
Neurology
, vol.45
, pp. 1305-1308
-
-
Zoldan, J.1
Friedberg, G.2
Livneh, M.3
Melamed, E.4
-
7
-
-
0028213564
-
Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis
-
Factor S, Brown D, Molho E, Podskalny D. Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis. Neurology 1994; 44: 544-546.
-
(1994)
Neurology
, vol.44
, pp. 544-546
-
-
Factor, S.1
Brown, D.2
Molho, E.3
Podskalny, D.4
-
8
-
-
0029064499
-
Low-dose clozapine in the treatment of levodopa induced mental disturbances in Parkinson's disease
-
Rabey J, Treves T, Neufeld M, Orlov E, Korczyn A. Low-dose clozapine in the treatment of levodopa induced mental disturbances in Parkinson's disease. Neurology 1995; 45: 1699-1701.
-
(1995)
Neurology
, vol.45
, pp. 1699-1701
-
-
Rabey, J.1
Treves, T.2
Neufeld, M.3
Orlov, E.4
Korczyn, A.5
-
9
-
-
0024418579
-
Clozapine in the treatment of psychosis in Parkinson's disease
-
Friedman J, Lannon M. Clozapine in the treatment of psychosis in Parkinson's disease. Neurology 1989; 39: 1219-1221.
-
(1989)
Neurology
, vol.39
, pp. 1219-1221
-
-
Friedman, J.1
Lannon, M.2
-
10
-
-
0028144914
-
Risperidone in Parkinson's disease
-
10
-
Ford B, Lynch T, Greene P. Risperidone in Parkinson's disease. [letter] Lancet 1994; 344: 681. 10
-
(1994)
Lancet
, vol.344
, pp. 681
-
-
Ford, B.1
Lynch, T.2
Greene, P.3
-
11
-
-
0029845563
-
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
-
Wolters E, Jansen E, Tuynman-Qua H, Bergmans P. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 1996; 47: 1085-1087.
-
(1996)
Neurology
, vol.47
, pp. 1085-1087
-
-
Wolters, E.1
Jansen, E.2
Tuynman-Qua, H.3
Bergmans, P.4
-
12
-
-
0023698509
-
Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease
-
Ostergaard K, Dupont E. Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease, [letter] Acta Neurol Scand 1988: 78: 349-350.
-
(1988)
Acta Neurol Scand
, vol.78
, pp. 349-350
-
-
Ostergaard, K.1
Dupont, E.2
-
13
-
-
0026000655
-
Clozapine is beneficial for psychosis in Parkinson's disease
-
Kahn N, Freeman A, Juncos J, Manning M, Watts R. Clozapine is beneficial for psychosis in Parkinson's disease. Neurology 1991; 41: 1699-1701.
-
(1991)
Neurology
, vol.41
, pp. 1699-1701
-
-
Kahn, N.1
Freeman, A.2
Juncos, J.3
Manning, M.4
Watts, R.5
-
14
-
-
0028356138
-
Risperidone for hallucinations in levodopa treated Parkinson's disease patients
-
Meco A, Bonifati V, Giustini P. Risperidone for hallucinations in levodopa treated Parkinson's disease patients. [letter] Lancet 1994; 343: 1370-1371.
-
(1994)
Lancet
, vol.343
, pp. 1370-1371
-
-
Meco, A.1
Bonifati, V.2
Giustini, P.3
-
15
-
-
0001991792
-
Health Accounting - Functional Assessment of the Long Term Patient
-
Kottke, Stilwell, Lehmann. (Editors). London: W.B. Saunders Company
-
Granger CV. Health Accounting - Functional Assessment of the Long Term Patient. In: Kottke, Stilwell, Lehmann. (Editors). Kruzen's Handbook of Physical Medicine and Rehabilitation, 3rd Edition. London: W.B. Saunders Company, 1982; 263.
-
(1982)
Kruzen's Handbook of Physical Medicine and Rehabilitation, 3rd Edition
, pp. 263
-
-
Granger, C.V.1
-
16
-
-
0016823810
-
'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
-
(1975)
J Psychiat Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
17
-
-
0014261678
-
Critical Analysis of the Disability in Parkinson's Disease
-
Webster DP. Critical Analysis of the Disability in Parkinson's Disease. Modern Treatment 1968; 5: 257-282.
-
(1968)
Modern Treatment
, vol.5
, pp. 257-282
-
-
Webster, D.P.1
-
18
-
-
0026055127
-
New Antipsychoptics: Classification, Efficacy and Adverse effects
-
Gerlach J. New Antipsychoptics: Classification, Efficacy and Adverse effects. Schizophrenia Bulletin 1986; 17: 289-309.
-
(1986)
Schizophrenia Bulletin
, vol.17
, pp. 289-309
-
-
Gerlach, J.1
-
19
-
-
0020079689
-
Pharmacology of hallucinations induced by long-term drug therapy
-
Goetz C, Tanner C, Klauwans H. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 1982; 139: 494-497.
-
(1982)
Am J Psychiatry
, vol.139
, pp. 494-497
-
-
Goetz, C.1
Tanner, C.2
Klauwans, H.3
-
20
-
-
0028943721
-
Risperidone in Parkinson's Disease
-
Tavares A. Risperidone in Parkinson's Disease. [letter] J Neurol Neurosurg Psychiatry 1995; 58: 521.
-
(1995)
J Neurol Neurosurg Psychiatry
, vol.58
, pp. 521
-
-
Tavares, A.1
-
21
-
-
0022492837
-
Performance deficit induced by low doses of dopamine agonists in rats toward a model for approaching the neurobiology of negative schizophrenic symptomology
-
Carnoy P, Soubrie P, Puech AJ et al. Performance deficit induced by low doses of dopamine agonists in rats toward a model for approaching the neurobiology of negative schizophrenic symptomology. Biological Psychiatry 1986; 21: 11-22.
-
(1986)
Biological Psychiatry
, vol.21
, pp. 11-22
-
-
Carnoy, P.1
Soubrie, P.2
Puech, A.J.3
-
22
-
-
0022552703
-
Differential modulation of dopamine D2 Receptors by chronic Haloperidol, Nitrendipine and Pimozide
-
Tecott LH, Kwong LL, Uhr S et al. Differential modulation of dopamine D2 Receptors by chronic Haloperidol, Nitrendipine and Pimozide. Biological Psychiatry 1986; 21: 1114-1122.
-
(1986)
Biological Psychiatry
, vol.21
, pp. 1114-1122
-
-
Tecott, L.H.1
Kwong, L.L.2
Uhr, S.3
-
24
-
-
0030944923
-
Olanzepine: A novel atypical neuroleptic agent
-
Reuss VI. Olanzepine: A novel atypical neuroleptic agent. Lancet 1997; 349: 1264-1265.
-
(1997)
Lancet
, vol.349
, pp. 1264-1265
-
-
Reuss, V.I.1
-
25
-
-
84920344380
-
-
Mims August/September 1998
-
Mims August/September 1998
-
-
-
|